Acute Infection clinical trials

Explore recruiting acute infection clinical trials.

Recruiting acute infection studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, placebo-controlled, blinded, parallel-group clinical trial to assess the efficacy of N-acetylcysteine in adults with acute infections or sepsis and evidence of liver dysfunction: the IMPACT-NAC trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Comparison of a personalized maintenance therapy based on the evolution of anti-desmoglein antibodies as biomarkers of pemphigus subclinical activity, with the standard treatment (rituximab + corticosteroids) in pemphigus - (RITUX 4)

France

Therapeutic use (Phase IV) EU CTIS Study details

Acute Infection trials by city

Acute Infection in Toronto Acute Infection in Vancouver Acute Infection in Montreal Acute Infection in Calgary Acute Infection in Edmonton Acute Infection in Ottawa Acute Infection in Winnipeg Acute Infection in Quebec City Acute Infection in Hamilton Acute Infection in Kitchener Acute Infection in London Acute Infection in Halifax Acute Infection in New York Acute Infection in Los Angeles Acute Infection in Chicago Acute Infection in Houston

Acute Infection clinical trials

Recruiting acute infection studies right now

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

Also recruiting in Europe

A randomized, placebo-controlled, blinded, parallel-group clinical trial to assess the efficacy of N-acetylcysteine in adults with acute infections or sepsis and evidence of liver dysfunction: the IMPACT-NAC trial

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT)

Comparison of a personalized maintenance therapy based on the evolution of anti-desmoglein antibodies as biomarkers of pemphigus subclinical activity, with the standard treatment (rituximab + corticosteroids) in pemphigus - (RITUX 4)

Acute Infection trials by city

Other conditions